Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H2, 2017

Price :
Published : Aug-2017
No. of Pages : 323

Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H2, 2017


GlobalData’s clinical trial report, “Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H2, 2017” provides an overview of Gastrointestinal Stromal Tumor (GIST) clinical trials scenario. This report provides top line data relating to the clinical trials on Gastrointestinal Stromal Tumor (GIST). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Cevec Pharmaceuticals GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Cevec Pharmaceuticals GmbH (Cevec) is a healthcare products company that offers production of biopharmaceuticals. The company produces recombinant glycoproteins and gene therapy vectors. It utilizes its CAP-Go technology developed expression system based on human cells, for the production of complexly glycosylated molecules including coagulation factors and other plasma proteins. Cevec's CAP-GT cell lines provide a novel platform for the industrial production of adenoviral vectors, AAV and lentiviral vectors. The company provides CGMP manufacturing, cell line development, process development, and contract manufacturing services among others. It out-licenses its expression technology platform and product candidates through partnerships with biotechnology and pharmaceutical compan......

Harvard Stem Cell Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Harvard Stem Cell Institute (HSCI), a subsidiary of Harvard University is a healthcare institute that conducts research on advance stem cell science using stem cell biology to develop new treatments and cures for disease. The institute provides research programs such as disease programs, core facilities, early-stage research, MD and PhD fellowship, and internship program. It undertakes various disease research programs, which include blood program, cardiovascular program, cancer program, diabetes program, kidney program, nervous system diseases program, and translation research program. The institute also offers clinical trial services. HSCI is headquartered in Cambridge, Massachusetts, the US. Harvard Stem Cell Institute - Pharmaceuticals & Healthcare - Deals and Alliances P......

Biowa Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Biowa Inc (BioWa), a subsidiary of Kyowa Hakko Kirin Co Ltd (KHK), is a science and technology company that provides out licensing of therapeutic antibody technologies of KHK. The company also developes fucose free monoclonal antibodies that increase cellular cytotoxicity. Its technology include potelligent, complegent and accretamab. BioWa's potelligent is used for ADCC enhancement of therapeutic antibodies; complegent is used for CDC enhancement of therapeutic antibodies. The company's accretamab is a combination of potelligent and complegent. Its ADCC/CDC enhanced monoclonal antibody based therapeutics used for other biotechnology and pharmaceutical companies for developing new therapies for the treatment of cancer and other diseases. The company partners include Bristol-Meye......

Geisinger Health System – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Geisinger Health System (GHS) is an integrated health services organization that provides medical and surgical specialties and sub-specialties, and related health services. It offers a range of medical services for patients suffering from diseases related to cardiology, ENT, gastroenterology, gynecology, cancer, obstetrics, ophthalmology, orthopedics and pediatrics, infectious diseases, and others. The organization also provides Life Flight regional helicopter ambulance services. It operates through several hospital campuses. GHS serves residents across several counties in central, south-central and northeast Pennsylvania; and southern New Jersey at AtlantiCare. The organization also offers medical education, research and community services. GHS is headquartered in Danville, Pen......

PhaseRx Inc (PZRX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary PhaseRx Inc (PhaseRx), formerly PhaseRx Pharmaceuticals Inc is a healthcare products provider that conducts research and develops RNA nanomedicines for the treatment of orphan diseases. The company discovers and develops drugs based on SMARTT polymer technology, which offers mRNA delivery techniques. Its products under clinical development include PRX-OTC, PRX-ASL and argininosuccinatesynthetase. PhaseRx's SMARTT polymer technology provides platform for the development of RNA-based drugs. The company offers products for the treatment of inherited metabolic disease and liver cancer. It has research collaborations with pharmaceutical and biotechnology companies. PhaseRx is headquartered in Seattle, Washington, the US. PhaseRx Inc (PZRX) - Pharmaceuticals & Healthcare - Deals an......

U.S. HealthWorks Medical Group – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary U.S. HealthWorks Medical Group (U.S. HealthWorks), a subsidiary of Dignity Health is a healthcare service provider that offers physical therapy, rehabilitation and medical review. The center's services include occupational medicine, urgent care, specialty care and therapy services. Its occupational medicine services comprise physical abilities testing, injury treatment, national MRO services, employment physical exams, specialty care, client communication system, medical surveillance and therapy services. U.S. HealthWorks also provides urgent care treatments such as infections, high blood pressure, allergy relief, urinary tract infections, cold and flu, rashes, minor burns and injuries, cuts and wounds, cholesterol and asthma. The center's specialty care offers services on ortho......

International Drug Development Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary International Drug Development Institute (IDDI) is a healthcare institute that offers clinical data collection, analysis, trial design and trial reporting services. The institute offers biostatistical services and eClinical services and risk-based monitoring programs. Its biostatistical and eClinical services comprise protocol design, central randomization, clinical data management, electronic data capture, biostatistics and medical writing. IDDI's risk-based monitoring services include risk indicator and central statistical monitoring. The institute provides clinical research services in therapeutics areas such as oncology, ophthalmology, cardiology and biosimilars. It caters to pharmaceutical companies, biotechs, start-ups, academic groups and CROs. IDDI is headquartered in Lo......

Camel-IDS NV – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Camel-IDS NV (Camel-IDS) is a biotechnology company which develops targeted radionuclide therapeutic solutions for the treatment of cancer. The company focuses on developing its lead compound radiopharmaceutical drug for treatment of Her2 positive cancer. Its technology platform is based on recombinant, small antigen-binding fragments derived from Camelidae heavy-chain-only antibodies (sdAbs) coupled with radioisotope to kill cancer cells. The company works in partnership with research institutions and organizations such as Vrije Universiteit Brussel (VUB), UZ Brussel, Fournier-Majoie Foundation, Biowin and VIB (Life Sciences Research Institute). Camel-IDS is headquartered in Brussels, Belgium. Camel-IDS NV - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides......

Edge Therapeutics Inc (EDGE) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Edge Therapeutics Inc (Edge Therapeutics) is a clinical-stage biotechnology company that discovers, develops and commercializes a range of hospital-based therapies. The company offers hospital based therapies capable of transforming treatment paradigms in the management of life-threatening, acute neurological conditions. Its lead pipeline products include EG-1962, a proprietary formulation, which is used to treat aneurysmal subarachnoid hemorrhage, is in Phase 3 clinical trials and EG-1964 is in preclinical stage used to prevent recurrent chronic subdural hematoma. The company's Precise, a proprietary, programmable, biodegradable polymer-based development platform develops products for the treatment of acute neurological conditions. Edge Therapeutics is headquartered in Berkeley......

Veristat LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Veristat LLC (Veristat), a subsidiary of Veristat Holding Inc is a clinical research organization that conducts clinical trials. The organization offers clinical monitoring, clinical project management, data management, CDISC implementation, biostatistics, medical writing, project management, regulatory submissions-FDA representation, and statistical and strategic consulting services. It helps its clients design, execute, analyze, standardize, and report clinical studies. Veristat supports study phases in all therapeutic areas for every type of medical product. It caters to organization which develop biological products, diagnostics agents, vaccines, medical devices, immune therapies and gene therapies. Veristat is headquartered in Southborough, Massachusetts, the US. Verista......